Irvine Scientific Announces Expansion Of BalanCD Product Line To Serve Vaccine Market
4/15/2014 9:19:10 AM
SANTA ANA, Calif.--(BUSINESS WIRE)--Irvine Scientific is pleased to announce the launch of its BalanCD™ MDCK cell culture medium, a next generation cell culture product responding to today’s requirements for media used in cell-based vaccine manufacturing. This new flagship product expands Irvine Scientific’s current BalanCD product portfolio of animal component-free and chemically-defined media with the addition of a new purpose-built product.
Help employers find you! Check out all the jobs and post your resume.
comments powered by